Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-10 12:54 pm Sale | 2021-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | BlackRock Inc. BLK | 125,391 4.800% | -1,029 (-0.81%) | Filing History |
| 2021-11-26 4:17 pm Purchase | 2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA | Lagunita LLC | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-11-26 4:16 pm Purchase | 2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA | Lagunita Biosciences LLC | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-11-24 2:27 pm Purchase | 2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA | Blumenkranz Mark S. | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 438,461 16.850% | 3,477 (+0.80%) | Filing History |
| 2021-10-14 5:00 pm Sale | 2021-10-12 | 13G | Kala Pharmaceuticals, Inc. KALA | ORBIMED ADVISORS LLC | 0 0.000% | -188,568 (Position Closed) | Filing History |
| 2021-03-01 6:09 pm Unchanged | 2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | ORBIMED ADVISORS LLC | 188,568 8.410% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:53 pm Purchase | 2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | ORBIMED ADVISORS LLC | 188,568 8.410% | 50,654 (+36.73%) | Filing History |
| 2021-02-12 4:08 pm Purchase | 2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Eventide Asset Management, LLC | 138,000 6.200% | 138,000 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | BlackRock Inc. BLK | 126,420 5.600% | 126,420 (New Position) | Filing History |